Your browser doesn't support javascript.
loading
Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20-28].
Tsimafeyeu, Ilya; Ludes-Meyers, John; Stepanova, Evgenia; Daeyaert, Frits; Khochenkov, Dmitry; Joose, Jean-Baptiste; Solomko, Eliso; Van Akene, Koen; Peretolchina, Nina; Yin, Wei; Ryabaya, Oxana; Byakhov, Mikhail; Tjulandin, Sergei.
Afiliação
  • Tsimafeyeu I; Ruspharmtech LLC, Saint Petersburg, Russia. Electronic address: tsimafeyeu@ruspharm.com.
  • Ludes-Meyers J; Altogen Labs, Austin, TX, USA.
  • Stepanova E; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Daeyaert F; FD Computing, Beerse, Belgium.
  • Khochenkov D; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Joose JB; EcoSynth, Oostende, Belgium.
  • Solomko E; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Van Akene K; EcoSynth, Oostende, Belgium.
  • Peretolchina N; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Yin W; Altogen Labs, Austin, TX, USA.
  • Ryabaya O; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Byakhov M; Moscow Clinical and Research Center, Moscow, Russia.
  • Tjulandin S; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
Eur J Cancer ; 70: 156, 2017 01.
Article em En | MEDLINE | ID: mdl-27919550
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article